Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury

JingLun Li,1 JiaoJiao Deng,2 JinXian Yuan,1 Jie Fu,1 XiaoLing Li,2 AiPing Tong,2 YueLong Wang,2 YangMei Chen,1 Gang Guo2 1Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 2State Key Laboratory of Biotherapy and Cancer Center, and Department of Neur...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li JL, Deng JJ, Yuan JX, Fu J, Li XL, Tong AP, Wang YL, Chen YM, Guo G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/69735de2b5d644248169ec6983b01b0a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:69735de2b5d644248169ec6983b01b0a
record_format dspace
spelling oai:doaj.org-article:69735de2b5d644248169ec6983b01b0a2021-12-02T01:32:10ZZonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury1178-2013https://doaj.org/article/69735de2b5d644248169ec6983b01b0a2017-03-01T00:00:00Zhttps://www.dovepress.com/zonisamide-loaded-triblock-copolymer-nanomicelles-as-a-novel-drug-deli-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013JingLun Li,1 JiaoJiao Deng,2 JinXian Yuan,1 Jie Fu,1 XiaoLing Li,2 AiPing Tong,2 YueLong Wang,2 YangMei Chen,1 Gang Guo2 1Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 2State Key Laboratory of Biotherapy and Cancer Center, and Department of Neurosurgery, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, People’s Republic of China Abstract: Spinal cord injury (SCI) commonly leads to lifelong disability due to the limited regenerative capacity of the adult central nervous system. Nanomicelles can be used as therapeutic systems to provide effective treatments for SCI. In this study, a novel triblock monomethyl poly(ethylene glycol)-poly(L-lactide)-poly(trimethylene carbonate) copolymer was successfully synthesized. Next, polymeric nanomicelles loaded with zonisamide (ZNS), a Food and Drug Administration-approved antiepileptic drug, were prepared and characterized. The ZNS-loaded micelles (ZNS-M) were further utilized for the treatment of SCI in vitro and in vivo. The obtained ZNS-M were ~50 nm in diameter with good solubility and dispersibility. Additionally, these controlled-release micelles showed significant antioxidative and neuron-protective effects in vitro. Finally, our results indicated that ZNS-M treatment could promote motor function recovery and could increase neuron and axon density in a hemisection SCI model. In summary, these results may provide an experimental basis for the use of ZNS-M as a clinically applicable therapeutic drug for the treatment of SCI in the future. Keywords: spinal cord injury, zonisamide, nanomicellesLi JLDeng JJYuan JXFu JLi XLTong APWang YLChen YMGuo GDove Medical PressarticleSpinal cord injuryzonisamidenano-micellesMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 2443-2456 (2017)
institution DOAJ
collection DOAJ
language EN
topic Spinal cord injury
zonisamide
nano-micelles
Medicine (General)
R5-920
spellingShingle Spinal cord injury
zonisamide
nano-micelles
Medicine (General)
R5-920
Li JL
Deng JJ
Yuan JX
Fu J
Li XL
Tong AP
Wang YL
Chen YM
Guo G
Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury
description JingLun Li,1 JiaoJiao Deng,2 JinXian Yuan,1 Jie Fu,1 XiaoLing Li,2 AiPing Tong,2 YueLong Wang,2 YangMei Chen,1 Gang Guo2 1Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 2State Key Laboratory of Biotherapy and Cancer Center, and Department of Neurosurgery, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, People’s Republic of China Abstract: Spinal cord injury (SCI) commonly leads to lifelong disability due to the limited regenerative capacity of the adult central nervous system. Nanomicelles can be used as therapeutic systems to provide effective treatments for SCI. In this study, a novel triblock monomethyl poly(ethylene glycol)-poly(L-lactide)-poly(trimethylene carbonate) copolymer was successfully synthesized. Next, polymeric nanomicelles loaded with zonisamide (ZNS), a Food and Drug Administration-approved antiepileptic drug, were prepared and characterized. The ZNS-loaded micelles (ZNS-M) were further utilized for the treatment of SCI in vitro and in vivo. The obtained ZNS-M were ~50 nm in diameter with good solubility and dispersibility. Additionally, these controlled-release micelles showed significant antioxidative and neuron-protective effects in vitro. Finally, our results indicated that ZNS-M treatment could promote motor function recovery and could increase neuron and axon density in a hemisection SCI model. In summary, these results may provide an experimental basis for the use of ZNS-M as a clinically applicable therapeutic drug for the treatment of SCI in the future. Keywords: spinal cord injury, zonisamide, nanomicelles
format article
author Li JL
Deng JJ
Yuan JX
Fu J
Li XL
Tong AP
Wang YL
Chen YM
Guo G
author_facet Li JL
Deng JJ
Yuan JX
Fu J
Li XL
Tong AP
Wang YL
Chen YM
Guo G
author_sort Li JL
title Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury
title_short Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury
title_full Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury
title_fullStr Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury
title_full_unstemmed Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury
title_sort zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/69735de2b5d644248169ec6983b01b0a
work_keys_str_mv AT lijl zonisamideloadedtriblockcopolymernanomicellesasanoveldrugdeliverysystemforthetreatmentofacutespinalcordinjury
AT dengjj zonisamideloadedtriblockcopolymernanomicellesasanoveldrugdeliverysystemforthetreatmentofacutespinalcordinjury
AT yuanjx zonisamideloadedtriblockcopolymernanomicellesasanoveldrugdeliverysystemforthetreatmentofacutespinalcordinjury
AT fuj zonisamideloadedtriblockcopolymernanomicellesasanoveldrugdeliverysystemforthetreatmentofacutespinalcordinjury
AT lixl zonisamideloadedtriblockcopolymernanomicellesasanoveldrugdeliverysystemforthetreatmentofacutespinalcordinjury
AT tongap zonisamideloadedtriblockcopolymernanomicellesasanoveldrugdeliverysystemforthetreatmentofacutespinalcordinjury
AT wangyl zonisamideloadedtriblockcopolymernanomicellesasanoveldrugdeliverysystemforthetreatmentofacutespinalcordinjury
AT chenym zonisamideloadedtriblockcopolymernanomicellesasanoveldrugdeliverysystemforthetreatmentofacutespinalcordinjury
AT guog zonisamideloadedtriblockcopolymernanomicellesasanoveldrugdeliverysystemforthetreatmentofacutespinalcordinjury
_version_ 1718403020774965248